Olanzapine as an add-on, preoperative antiemetic drug in high-risk patients for postoperative nausea and vomiting: a double-blind, randomized trial
2021
- 140Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage140
- Views122
- Downloads18
Dataset Description
We conducted a randomized clinical trial in patients with cancer at high risk on postoperative nausea and vomiting (PONV) with a history of previous chemotherapy-induced nausea and vomiting who received total intravenous anaesthesia, to determine whether olanzapine, as a prophylactic antiemetic added to intraoperative dexamethasone and ondansetron, reduces the incidence of PONV in the first 24 hours or between 24 and 48 hours after surgery. The secondary outcomes were the incidence of severe PONV, the length of stay at the postanaesthesia care unit, antiemetic use as needed, and side effects. The file has two tabs. One tab for the analysis by intention to treat and another for the data dictionary
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know